Owens and Minor
we have some technical reasons here.
1. RSI divergence on the weekly chart: 2025 Februar and April made a doubla bottom formation, with higher RSI in April
2. $6.88 is a year S1 pivot level
3. At $14.1 is a gap wacthing us, promising a 100% upside potential
Fundamental reasons:
1. The whole healthcare sector is down because US government, can be a good contrarian play for 2025 or 2026
2. This spring, Coliseum Capital management bought around 4M Shares, and now holding 31% of the company.
The share price can decline further, breaking the $6.0 level for a short period of time. But it didn't happened in the April panic. $ 5.89 can be a good stop-loss level alltough if you can handle -18% loss.
But i'm waiting for upside momentum in OMI.
we have some technical reasons here.
1. RSI divergence on the weekly chart: 2025 Februar and April made a doubla bottom formation, with higher RSI in April
2. $6.88 is a year S1 pivot level
3. At $14.1 is a gap wacthing us, promising a 100% upside potential
Fundamental reasons:
1. The whole healthcare sector is down because US government, can be a good contrarian play for 2025 or 2026
2. This spring, Coliseum Capital management bought around 4M Shares, and now holding 31% of the company.
The share price can decline further, breaking the $6.0 level for a short period of time. But it didn't happened in the April panic. $ 5.89 can be a good stop-loss level alltough if you can handle -18% loss.
But i'm waiting for upside momentum in OMI.
Trade active
Bought at 7.22Note
OWENS & MINOR AND ROTECH HEALTHCARE MUTUALLY AGREE TO TERMINATE PREVIOUSLY ANNOUNCED ACQUISITIONOWENS & MINOR INC - TO REDEEM $1 BILLION NOTES ISSUED IN APRIL 2025
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.